Update from the International Society of Oncology Pharmacy Practitioners (ISOPP)

Revised ISOPP Standards of Practice

Hot off the press! The revised International Society of Oncology Pharmacy Practitioners (ISOPP) Standards of Practice has been published in the Journal of Oncology Pharmacy Practice and posted to ISOPP’s website. ISOPP’s Standards of Practice in cancer pharmacy communicate to healthcare professionals the roles and responsibilities of oncology pharmacists and provide a benchmark to evaluate the quality of services and patient care.

Click here for more information.


ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

The position paper developed by the International Society of Oncology Pharmacy Practitioners (ISOPP)  Immunotherapy Task Force has been published online ahead of print by the Journal of Oncology Pharmacy Practice.

The position statement describes four key recommendations:

1) Participation as an integrated, collaborative member of the multidisciplinary health care team (MHT);

2) Provision of education and training for patients, students, residents, fellows and other members of the MHT;

3) Involvement in clinical governance to optimize the use of immune checkpoint inhibitors and

4) Involvement in research and development in the field of immunotherapy.

You can view the paper on the ISOPP website here.



The International Society of Oncology Pharmacy Practitioners (ISOPP) offers educational opportunities specific to the needs of oncology pharmacy practitioners worldwide. Two opportunities for ISOPP members to share and expand knowledge, facilitated by ISOPP leaders and oncology pharmacy experts, are:


Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program – this consists of 10 online courses (total of 25 hours) and an opportunity to meet at ISOPP’s 2023 Symposium in Spain to expand the Biosimilars Expert Network. Access to part 1 (Modules 1 to 4) is open! Access to following modules coming soon!

Module 1 – Fundamentals of Biosimilars use in contemporary oncology clinical practice
Module 2 – Fundamentals in oncology pharmacy practice
Module 3 – Management of breast cancer
Module 4 – Management of colorectal cancer

If you complete the accredited version, you will receive a Certificate of Completion issued by the California Society of Health-System Pharmacists (CSHP), which will state the Continuing Education credits (25) earned. Visit www.isopp.org/opab for more information and spread the word using #ISOPPOPAB.

Registration for OPAB is complimentary for ISOPP members.

Not a member? Join ISOPP! Note: You must be member of ISOPP in 2022 to be eligible for complimentary registration to OPAB.


ISOPP 2023 Symposium – taking place March 2-5, 2023 at the Barceló Sevilla Renacimiento in Sevilla, Spain. Save the dates and watch for program announcements!

o    Engage in hot topics led by facilitators on a wide range of timely topics

o    Gain valuable insights during Sponsored Symposia

o    Connect through Discussion Forums and a Meeting Networking Hub with colleagues from around the world

o    Participate in ISOPP’s Annual General Meeting to stay informed of past and upcoming activities and interact with ISOPP’s leadership to guide the future of ISOPP.

Visit http://www.isopp2023.org/ for more information and spread the word using #ISOPP2023.

Latest News

By BOPA on 12th May 2022

REGISTRATION NOW OPEN – The 25th Annual BOPA Symposium, 7-9 October, Liverpool

An important date for your diaries: The 25th British Oncology Pharmacy Association (BOPA) Annual Symposium (7th – 9th October). Oncology and haematology are ever-changing landscapes and this year we are looking to…

Read article
By BOPA Committee on 11th May 2022

Vote for the 2023 Symposium Venue: PAID members

The BOPA committee are giving all PAID members of BOPA the opportunity to help inform the choice of venue for the 2023 BOPA symposium. If you wish to take part…

Read article
By BOPA Committee on 11th May 2022

PUBLIC CONSULTATION NOW OPEN ** Draft International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) **

The ADDIKD draft guideline is open for public consultation until midnight (AEST) 31st May 2022.  The BOPA Committee would appreciate your input with this process. The Draft Guideline can be…

Read article
By BOPA Committee on 11th May 2022

UK Oncology Forum

Dear Colleague Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused. However –…

Read article

25th BOPA Symposium 2022

7th to 9th October 2022 at The ACC Liverpool

Members: www.bopa.org.uk/2022-members-symposium-link/
Non members: Contact Media1Productions: [email protected]
Please see Key information before for accommodation information.

Please click here to view the latest agenda.

Early-bird rate applies up until Monday 22nd August 2022

Everything you need to know